Cellosaurus cell line CH-01 (CVCL

Cross-references
Cell line name	CH-01
Synonyms	Clone 3; anti-CHRNB2 mAb-3
Accession	CVCL_C7NF
Resource Identification Initiative	To cite this cell line use: CH-01 (RRID:CVCL_C7NF)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-02857. Monoclonal antibody isotype: Not specified. Monoclonal antibody target: UniProtKB; P17787; Human CHRNB2.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_3412 (P3X63Ag8U.1)
Category	Hybridoma
Publications	PubMed=34331011; DOI=10.1038/s41388-021-01945-9 Mitsuro Kanda, Dai Shimizu, Shunsuke Nakamura, Koichi Sawaki, Shinichi Umeda, Takashi Miwa, Haruyoshi Tanaka, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka ...Show all 15 authors... , Goro Nakayama, Yohei Iguchi, Masahisa Katsuno, Yasuhiro Kodera; Show fewer authors Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells. Oncogene 40:5495-5504(2021) Patent=US12098205 Mitsuro Kanda; Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs. Patent number US12098205, 24-Sep-2024
Encyclopedic resources	Wikidata; Q117704239
Entry history
Entry creation	21-Mar-2023
Last entry update	10-Apr-2025
Version number	4